Pascual-Goñi, Elba http://orcid.org/0000-0001-7336-4305
Martín-Aguilar, Lorena
Lleixà, Cinta
Martínez-Martínez, Laura
Simón-Talero, Manuel J.
Díaz-Manera, Jordi
Cortés-Vicente, Elena
Rojas-García, Ricard
Moga, Esther
Juárez, Cándido
Illa, Isabel
Querol, Luis http://orcid.org/0000-0002-4289-8264
Funding for this research was provided by:
Government of Catalonia | Departament de Salut, Generalitat de Catalunya (SLT006/17/00131)
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (FIS16/00627)
Article History
Received: 31 January 2019
Accepted: 2 April 2019
First Online: 16 April 2019
Change Date: 10 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-021-81911-3
Competing Interests
: EP-G, LM-A, CL, LM-M, MJS-T, JD-M, EC-V, RR-G, EM and CJ declare no competing interests. LQ has provided expert testimony for Grifols, Genzyme and CSL Behring and received research funds from Novartis Spain and Grifols (Spin Award). II provided expert testimony and received speaking fees and travel grants from Pfizer.